Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
D A Herrington(University of Maryland, Baltimore), R S Nussenzweig, Joseph F. Cortese, Elizabeth Nardin(Health First), D. F. Clyde(University of Maryland, Baltimore), James R. Murphy(University of Liverpool), Jonathan R. Davis(University of Maryland, Baltimore), R S Bank, Shahida Baqar(Naval Medical Research Command), D DiJohn
PubMed
January 1, 1990
Cited by 27
Related Papers
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations
|Clinical Infectious Diseases|1983|754
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|Nature|1987|503
Variants in FAM13A are associated with chronic obstructive pulmonary disease
|Nature Genetics|2010|423